4-(4-(((R)-1-Butyl-3-((R)-cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl)methyl)phenoxy)benzoic acid

Catalog No. :
ACJNZF542
CAS No. :
461443-59-4
Molecular Formula :
C33H43N3O6
Molecular Weight :
577.72

IUPAC Name:4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl)methyl)phenoxy)benzoic acid

4-(4-(((R)-1-Butyl-3-((R)-cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl)methyl)phenoxy)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg97%$559.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-(((R)-1-Butyl-3-((R)-cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl)methyl)phenoxy)benzoic acid
IUPAC Name4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl)methyl)phenoxy)benzoic acid
Molecular FormulaC33H43N3O6
Molecular Weight577.72
SMILES[H][C@@](NC(C12CCN(CC3=CC=C(OC4=CC=C(C(O)=O)C=C4)C=C3)CC2)=O)([C@H](O)C5CCCCC5)C(N1CCCC)=O
InChI KeyGWNOTCOIYUNTQP-FQLXRVMXSA-N
SynonymAK-602 | GW 873140 | GW873140A
CAS No.461443-59-4
PubChem CID3001322

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACJNZF542 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJNZF542 route product structure diagram
    ACJNZF542461443-59-4
Inquiry

2. ACJNZF542 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJNZF542 route product structure diagram
    ACJNZF542461443-59-4
Inquiry

Comments (0)